MPLN Partners with ArcherDX to Offer Archer NGS Assays to Global Biopharma Customers


ArcherDX, Inc., has announced that Molecular Pathology Laboratory Network, Inc. is now a Certified Service Provider of Archer A FusionPlexA NGS assays. MPLN will offer a custom sarcoma analysis service that includes the FusionPlex Sarcoma NGS assay as part of their services to customers in the biotechnology and pharmaceutical industries.



from Biotech News